Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue
Related news
- This is where earnings growth is coming from in Q3 – Citadel Securities’ Rubner
- Brookdale in pact with Welltower to acquire 30 leased communities for $290M
-
Don't let inflation bite — how to hedge with TIPS, commodities and infrastructure funds
- SAIC names Kenneth Crews as new CFO
- Applied Materials retreats 7% as losing streak reaches six sessions
-
JPMorgan Chase blocks outside AI agents like Muse, Instinct from directly accessing accounts
-
Six Flags shares decline following deadly roller coaster incident
- B&G Foods sells more assets as looks to simplify the portfolio